PortfoliosLab logo

Atossa Therapeutics, Inc. (ATOS)

Equity · Currency in USD · Last updated Dec 1, 2022

Company Info

ISINUS04962H5063
CUSIP04962H506
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.75
Year Range$0.75 - $2.24
EMA (50)$0.85
EMA (200)$1.12
Average Volume$434.84K
Market Capitalization$94.97M

ATOSShare Price Chart


Loading data...

ATOSPerformance

The chart shows the growth of $10,000 invested in Atossa Therapeutics, Inc. in Nov 2012 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $10 for a total return of roughly -99.90%. All prices are adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%JulyAugustSeptemberOctoberNovember
-28.57%
-0.69%
ATOS (Atossa Therapeutics, Inc.)
Benchmark (^GSPC)

ATOSCompare to other instruments

Search for stocks, ETFs, and funds to compare with ATOS

ATOSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-23.47%4.59%
6M-22.68%-1.26%
YTD-53.12%-14.39%
1Y-65.12%-12.36%
5Y-28.35%9.05%
10Y-50.39%11.23%

ATOSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-14.38%-10.95%2.46%-19.20%-3.96%12.37%-13.76%-2.13%-9.78%19.28%-24.24%
2021132.63%23.08%-22.43%10.43%38.20%96.27%-52.69%27.09%-14.21%-21.17%-11.67%-29.52%
2020-5.73%-18.24%9.92%63.91%9.17%59.66%-0.53%-32.54%-5.10%-38.43%18.12%-46.02%
201927.45%13.08%139.46%-15.06%-14.38%-0.39%-18.43%-4.29%-1.54%-18.88%-14.47%15.44%
2018204.18%-17.50%-32.42%-18.16%-26.71%-31.46%2.73%-5.31%-18.22%-25.14%-12.98%-10.53%
2017-2.84%5.11%-47.21%-21.98%-23.77%10.62%-32.01%26.18%23.54%-20.79%-21.39%-20.30%
2016-19.69%61.48%-17.11%10.47%-11.84%-16.42%-10.25%-34.21%-15.32%-12.38%10.87%-30.88%
2015-18.18%64.10%-6.25%-21.11%9.86%-27.56%-9.73%-22.55%-2.53%-16.87%-21.89%-36.00%
20146.47%-10.93%-23.18%-27.22%19.51%14.29%-0.00%10.12%-27.03%-19.26%-17.43%58.89%
201334.36%22.14%36.72%-23.66%-33.23%16.59%-8.65%-3.16%22.18%-68.68%31.25%0.43%
201212.59%-14.47%

ATOSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Atossa Therapeutics, Inc. Sharpe ratio is -0.97. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.20-1.00-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovember
-0.97
-0.44
ATOS (Atossa Therapeutics, Inc.)
Benchmark (^GSPC)

ATOSDividend History


Atossa Therapeutics, Inc. doesn't pay dividends

ATOSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-99.97%
-14.94%
ATOS (Atossa Therapeutics, Inc.)
Benchmark (^GSPC)

ATOSWorst Drawdowns

The table below shows the maximum drawdowns of the Atossa Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Atossa Therapeutics, Inc. is 99.97%, recorded on Nov 30, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.97%Mar 20, 20132444Nov 30, 2022
-23.85%Dec 12, 201213Jan 2, 201318Jan 29, 201331
-20%Feb 13, 201316Mar 7, 20137Mar 18, 201323
-8.57%Nov 16, 201211Dec 3, 20124Dec 7, 201215
-6.52%Nov 13, 20122Nov 14, 20121Nov 15, 20123
-4.85%Feb 4, 20131Feb 4, 20131Feb 5, 20132
-1.89%Jan 30, 20131Jan 30, 20131Jan 31, 20132

ATOSVolatility Chart

Current Atossa Therapeutics, Inc. volatility is 53.29%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%JulyAugustSeptemberOctoberNovember
53.29%
20.52%
ATOS (Atossa Therapeutics, Inc.)
Benchmark (^GSPC)